Oncology Molecular Diagnostics Market Growth, Size, Share, Key Players, and Forecast by 2031

Historic Data: 2021-2023   |   Base Year: 2024   |   Forecast Period: 2025-2031

Oncology Molecular Diagnostics Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage : by Type (Breast Cancer, Prostate Cancer, Colorectal Cancer, Cervical Cancer, Liver Cancer, Lung Cancer, Blood Cancer, Kidney Cancer); Product (Instruments, Reagents); Technology (PCR, In Situ Hybridization, Isothermal Nucleic Acid Amplification Technology); End User (Hospitals, Diagnostic Centers); and Geography (North America, Europe, Asia Pacific, and South and Central America)

  • Report Date : Sep 2025
  • Report Code : TIPRE00040738
  • Category : Life Sciences
  • Status : Upcoming
  • Available Report Formats : pdf-format excel-format
  • No. of Pages : 150

The Oncology Molecular Diagnostics Market is expected to register a CAGR of 13.7% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031.

The report is segmented by Type (Breast Cancer, Prostate Cancer, Colorectal Cancer, Cervical Cancer, Liver Cancer, Lung Cancer, Blood Cancer, Kidney Cancer, Others), Product (Instruments, Reagents, Others), Test Location (Clinics and Other Establishments, Point of Care), Technology (PCR, In Situ Hybridization, Isothermal Nucleic Acid Amplification Technology (INAAT), Chips and Microarrays, Mass Spectrometry, Sequencing, Transcription Mediated Amplification, Others), End User (Hospitals, Diagnostic Centers)

Purpose of the Report

The report Oncology Molecular Diagnostics Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:

  • Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
  • Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
  • Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.

Oncology Molecular Diagnostics Market Segmentation

Type

  • Breast Cancer
  • Prostate Cancer
  • Colorectal Cancer
  • Cervical Cancer
  • Liver Cancer
  • Lung Cancer
  • Blood Cancer
  • Kidney Cancer

Product

  • Instruments
  • Reagents

Technology

  • PCR
  • In Situ Hybridization
  • Isothermal Nucleic Acid Amplification Technology

End User

  • Hospitals
  • Diagnostic Centers

Customize This Report To Suit Your Requirement

You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities

Oncology Molecular Diagnostics Market: Strategic Insights

oncology-molecular-diagnostics-market
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Oncology Molecular Diagnostics Market Growth Drivers

  • Rising Cancer Incidence: The increasing global prevalence of cancer is a major driver of the oncology molecular diagnostics market. As cancer rates rise, the demand for advanced diagnostic methods grows. Molecular diagnostics enable early detection and targeted treatment, improving patient outcomes, and leading to increased adoption across healthcare facilities worldwide.
  • Advancements in Molecular Biology: The continuous advancements in molecular biology, including next-generation sequencing (NGS), PCR, and liquid biopsy technologies, are fueling the oncology molecular diagnostics market. These innovations provide more precise, efficient, and non-invasive testing methods, enabling accurate cancer diagnosis, monitoring, and treatment, driving growth in the sector.
  • Personalized Medicine Demand: Personalized medicine, which tailors treatments based on individual genetic profiles, is gaining traction. Molecular diagnostics play a vital role in identifying specific mutations and biomarkers, enabling more accurate and effective treatment options for cancer patients. This shift towards personalized care is significantly driving the market.

Oncology Molecular Diagnostics Market Future Trends

  • Integration of Artificial Intelligence (AI): AI is increasingly being integrated into oncology molecular diagnostics, particularly for data analysis and predictive modeling. AI can process vast amounts of genetic data, identifying patterns that help in early diagnosis, prognosis, and treatment selection, enhancing the overall efficacy of molecular diagnostics.
  • Non-invasive Diagnostic Methods: There is a growing trend towards non-invasive diagnostic techniques, such as liquid biopsies. These methods use blood samples to detect cancer biomarkers, offering less risk, faster results, and improved patient compliance compared to traditional tissue biopsies, driving the growth of the molecular diagnostics market.
  • Rise in Point-of-Care Testing: The demand for point-of-care (POC) testing is increasing in oncology molecular diagnostics. With the need for quicker, accessible results, POC tests are becoming more prevalent. These tests allow immediate clinical decisions and improve patient outcomes, leading to a shift towards decentralized testing options.

Oncology Molecular Diagnostics Market Opportunities

  • Emerging Markets: There is significant growth potential for oncology molecular diagnostics in emerging markets such as China, India, and Latin America. As healthcare infrastructure improves and cancer awareness rises, the demand for advanced diagnostic technologies is expected to grow, providing new opportunities for market expansion.
  • Partnerships and Collaborations: Collaborations between diagnostic companies and pharmaceutical firms are creating opportunities for new molecular diagnostic tests. These partnerships facilitate the development of cutting-edge diagnostic solutions tailored to specific cancer types and treatments, accelerating market growth and innovation.
  • Increased Research and Development Investment: Increased R&D investment in oncology diagnostics presents growth opportunities. The development of novel biomarkers and diagnostic platforms can enhance the accuracy and effectiveness of cancer detection, improving early diagnosis and treatment planning.

Oncology Molecular Diagnostics Market Regional Insights

The regional trends and factors influencing the Oncology Molecular Diagnostics Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Oncology Molecular Diagnostics Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

oncology-molecular-diagnostics-market-global-geography
  • Get the Regional Specific Data for Oncology Molecular Diagnostics Market

Oncology Molecular Diagnostics Market Report Scope

Report Attribute Details
Market size in 2024 US$ XX million
Market Size by 2031 US$ XX Million
Global CAGR (2025 - 2031) 13.7%
Historical Data 2021-2023
Forecast period 2025-2031
Segments Covered By Type
  • Breast Cancer
  • Prostate Cancer
  • Colorectal Cancer
  • Cervical Cancer
  • Liver Cancer
  • Lung Cancer
  • Blood Cancer
  • Kidney Cancer
By Product
  • Instruments
  • Reagents
By Technology
  • PCR
  • In Situ Hybridization
  • Isothermal Nucleic Acid Amplification Technology
By End User
  • Hospitals
  • Diagnostic Centers
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Thermo Fisher Scientific
  • Roche Diagnostics
  • Abbott Laboratories
  • Illumina, Inc.
  • Qiagen
  • Siemens Healthineers
  • Agilent Technologies
  • Hologic, Inc.
  • Bio-Rad Laboratories
  • Myriad Genetics.

  • Oncology Molecular Diagnostics Market Players Density: Understanding Its Impact on Business Dynamics

    The Oncology Molecular Diagnostics Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

    Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.

    Major Companies operating in the Oncology Molecular Diagnostics Market are:

    1. Thermo Fisher Scientific
    2. Roche Diagnostics
    3. Abbott Laboratories
    4. Illumina, Inc.
    5. Qiagen
    6. Siemens Healthineers

    Disclaimer: The companies listed above are not ranked in any particular order.


    oncology-molecular-diagnostics-market-cagr

    • Get the Oncology Molecular Diagnostics Market top key players overview

    Key Selling Points

    • Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Oncology Molecular Diagnostics Market, providing a holistic landscape.
    • Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
    • Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
    • Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.

    The research report on the Oncology Molecular Diagnostics Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.


    Frequently Asked Questions

    What is driving the growth of the oncology molecular diagnostics market?

    The growing incidence of cancer, advancements in molecular biology, and the shift toward personalized medicine are key factors driving the market.

    What are the current trends in the oncology molecular diagnostics market?

    AI integration, non-invasive diagnostic methods, and the rise of point-of-care testing are among the key trends in the market.

    What are the growth opportunities in oncology molecular diagnostics?

    Opportunities lie in emerging markets, strategic partnerships, and continued R&D investment, particularly in novel diagnostic technologies.

    How is AI impacting oncology molecular diagnostics?

    AI enhances data analysis, identifying genetic patterns that aid in cancer diagnosis and treatment, improving efficiency and accuracy.

    What are some non-invasive techniques gaining popularity in the market?

    Liquid biopsies and other non-invasive methods are gaining traction, offering faster, safer, and more convenient diagnostic options.

    What is the expected CAGR for the oncology molecular diagnostics market?

    The oncology molecular diagnostics market is expected to grow at a CAGR of 13.7% from 2024 to 2030.

    Mrinal Kerhalkar
    Mrinal Kerhalkar
    Manager,
    Market Research & Consulting

    Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

    Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

    • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
    • PEST and SWOT Analysis
    • Market Size Value / Volume - Global, Regional, Country
    • Industry and Competitive Landscape
    • Excel Dataset

    Testimonials

    Reason to Buy

    • Informed Decision-Making
    • Understanding Market Dynamics
    • Competitive Analysis
    • Identifying Emerging Markets
    • Customer Insights
    • Market Forecasts
    • Risk Mitigation
    • Boosting Operational Efficiency
    • Strategic Planning
    • Investment Justification
    • Tracking Industry Innovations
    • Aligning with Regulatory Trends
    Your Key Concerns Addressed - Question & Answer
    Can I view a sample of the report before purchasing?

    Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.

    Is analyst support included with the purchase?

    Absolutely — analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.

    What are the next steps once I place an order?

    Once your order is successfully placed, you will receive a confirmation email along with your invoice.

    • For published reports: You’ll receive access to the report within 4–6 working hours via a secured email sent to your email.
    • For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.

    Can the report be tailored to suit my specific needs?

    We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we’ll be happy to provide a customized proposal or scope.

    In what format is the report delivered?

    The report is available in either PDF format or as an Excel dataset, depending on the license you choose.

    The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
    Please review the license options at checkout or contact us to confirm which formats are included with your purchase.

    How secure is the payment process on your platform?

    Our payment process is fully secure and PCI-DSS compliant.

    We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
    You can make your purchase with confidence, knowing your personal and financial information is safe with us.

    Do you provide special pricing for buying multiple reports?

    Yes, we do offer special pricing for bulk purchases.
    If you're interested in purchasing multiple reports, we’re happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you’re considering, and we’ll share a personalized quote.

    Can I connect with your team to discuss the report before buying?

    Yes, absolutely.
    Our team is available to help you make an informed decision. Whether you have questions about the report’s scope, methodology, customization options, or which license suits you best, we’re here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.

    Will I get a billing invoice upon purchase?

    Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
    If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we’ll be happy to assist.

    Is there support available if I can’t access my report?

    Yes, certainly.
    If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we’ll ensure the issue is resolved quickly so you can access your report without interruption.

    Our Clients
    Oncology Molecular Diagnostics Market
    Connect With Expert

    • Thermo Fisher Scientific

    • Roche Diagnostics

    • Abbott Laboratories

    • Illumina, Inc.

    • Qiagen

    • Siemens Healthineers

    • Agilent Technologies

    • Hologic, Inc.

    • Bio-Rad Laboratories

    • Myriad Genetics.

    Sales Assistance
    US: +1-646-491-9876
    UK: +44-20-8125-4005
    Email: sales@theinsightpartners.com
    Chat with us
    DUNS Logo
    87-673-9708
    ISO Certified Logo
    ISO 9001:2015
    ISO Certified Logo